-transparent.png){kind=logo}
Studies on hypotensive agents. Synthesis of 1-substituted 3-(2-chlorophenyl)-6-ethoxycarbonyl-5,7-dimethyl-2,4(1H,3H)-quinazoline diones. 1991
Institute for Medical and Dental Engineering, Tokyo Medical and Dental University, Japan.
3-(2-Chlorophenyl)-6-ethoxycarbonyl-5,7-dimethyl-2,4(1H,3H)-quinazoline dione was newly prepared. 1-Hydrogen atoms of the compound were variously substituted in order to test for their hypotensive activities on relaxing effects of the blood vessels. The compounds with 2-(1-pyrrolidinyl) ethyl, 2-(1-piperidinyl)ethyl, 3-(dimethylamino)propyl, and 3-(N-benzyl-N-methylamino)propyl moieties showed significant activity. The 2-(1-piperidinyl)ethyl compound possessed activity approximately 23 times more potent than papaverine, however, it was less potent than cinnarizine.
Related Publications
Y Eguchi, and
F Sasaki, and
A Sugimoto, and
H Ebisawa, and
M Ishikawa
March 2009,
Organic letters,
Y Eguchi, and
F Sasaki, and
A Sugimoto, and
H Ebisawa, and
M Ishikawa
August 2011,
Acta crystallographica. Section E, Structure reports online,
Y Eguchi, and
F Sasaki, and
A Sugimoto, and
H Ebisawa, and
M Ishikawa
September 1992,
Journal of medicinal chemistry,
Y Eguchi, and
F Sasaki, and
A Sugimoto, and
H Ebisawa, and
M Ishikawa
November 1965,
Journal of medicinal chemistry,
Y Eguchi, and
F Sasaki, and
A Sugimoto, and
H Ebisawa, and
M Ishikawa
February 2012,
European journal of medicinal chemistry,
Y Eguchi, and
F Sasaki, and
A Sugimoto, and
H Ebisawa, and
M Ishikawa
June 2017,
ACS medicinal chemistry letters,
Y Eguchi, and
F Sasaki, and
A Sugimoto, and
H Ebisawa, and
M Ishikawa
March 1993,
Farmaco (Societa chimica italiana : 1989),
Y Eguchi, and
F Sasaki, and
A Sugimoto, and
H Ebisawa, and
M Ishikawa
April 2014,
Yao xue xue bao = Acta pharmaceutica Sinica,
Y Eguchi, and
F Sasaki, and
A Sugimoto, and
H Ebisawa, and
M Ishikawa
January 2014,
Chemical & pharmaceutical bulletin,
Y Eguchi, and
F Sasaki, and
A Sugimoto, and
H Ebisawa, and
M Ishikawa
March 1995,
Archiv der Pharmazie,
